Back to List View Graph View

C-C motif chemokine ligand 2

C-C motif chemokine ligand 2 (CCL2), widely known as Monocyte Chemoattractant Protein-1 (MCP-1), is a small secreted cytokine belonging to the CC chemokine family.

Where the papers sit

10 papers from the last 6 months study C-C motif chemokine ligand 2 directly · updated from PubMed 16 Nov 2026

  • Macrophage Immune Suppression

    Macrophage recruitment and immune suppression are central across glioblastoma, lung adenocarcinoma, and other inflammatory settings. Radiotherapy-induced chemokines are being redirected with molecular decoys, while ASP1012 seeks durable memory T-cell responses. Multi-omics studies prioritize GINS1, the CCL2/TIMP1 axis, and microbiota-derived metabolites as prognostic or immune-regulatory markers. The recurring goal is to convert suppressive microenvironments into more responsive ones, but validation beyond computational associations remains open.

    5 papers · 50%

  • Chemokine-Linked Inflammation

    Chemokine-linked inflammation appears in breast-tumor treatment, chemotherapy-associated cytokine changes, and Glaesserella parasuis infection. CCL2/CCL8 diphtheria-toxin peptides represent a targeted cytotoxic approach in breast tumors. Exercise during chemotherapy is being assessed through systemic cytokine and muscle-autophagy responses. No unified direction is evident beyond connecting chemokine signatures with immune or inflammatory states.

    3 papers · 30%

  • Early Kidney Injury

    Early detection and prevention of kidney injury dominate this work. ANGPT2, LCN2, glomerular filtration rate, and urea are evaluated as indicators of renal damage and progression in Chagas disease. Anti-CCL2-conjugated platelets reduce monocyte infiltration during allograft and ischemia-reperfusion injury. The field is moving toward combining biomarker surveillance with targeted control of inflammatory recruitment, although broader clinical validation remains needed.

    2 papers · 20%

Papers

The 10 papers from the last 6 months that study C-C motif chemokine ligand 2 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Macrophage Immune Suppression (5)
  1. Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis. PloS one · 13 Aug 2026 PMID 42594087
  2. Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma. Cell cycle (Georgetown, Tex.) · 15 Jul 2026 PMID 42454783
  3. The oncolytic viral immunotherapy ASP1012 optimizes memory T cell responses after systemic delivery. Molecular therapy : the journal of the American Society of Gene Therapy · 9 Jul 2026 PMID 42421317
  4. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  5. Multi-omics analysis identifies GINS1 as a prognostic biomarker in lung adenocarcinoma, linked to macrophage polarization and tumor cell survival. Discover oncology · 15 Jun 2026 PMID 42295485
Chemokine-Linked Inflammation (3)
  1. Integration of bulk RNA-seq and scRNA-seq reveals cell subsets and gene signatures associated with Glaesserella parasuis infection. BMC genomics · 7 Jul 2026 PMID 42410501
  2. Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides. Cancer biology & therapy · 2 Jul 2026 PMID 42390481
  3. The Effect of Strength Training During Chemotherapy in Women With Breast Cancer on Serum Cytokine Concentrations and Skeletal Muscle Autophagy-Related Proteins. European journal of sport science · 25 Jun 2026 PMID 42350900
Early Kidney Injury (2)
  1. Renal and endothelial biomarkers in Chagas disease in the Brazilian Amazon region: Early indicators of kidney injury and disease progression. PloS one · 17 Jul 2026 PMID 42467670
  2. Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration. Journal of hepatology · 1 Jul 2026 PMID 42385858

By study type

Clinical trials (1)
  1. The Effect of Strength Training During Chemotherapy in Women With Breast Cancer on Serum Cytokine Concentrations and Skeletal Muscle Autophagy-Related Proteins. European journal of sport science · 25 Jun 2026 PMID 42350900
Observational studies and case reports (1)
  1. Renal and endothelial biomarkers in Chagas disease in the Brazilian Amazon region: Early indicators of kidney injury and disease progression. PloS one · 17 Jul 2026 PMID 42467670
Human data, design not indexed (1)
  1. Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis. PloS one · 13 Aug 2026 PMID 42594087
Preclinical: animal, cell and lab studies (3)
  1. The oncolytic viral immunotherapy ASP1012 optimizes memory T cell responses after systemic delivery. Molecular therapy : the journal of the American Society of Gene Therapy · 9 Jul 2026 PMID 42421317
  2. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  3. Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides. Cancer biology & therapy · 2 Jul 2026 PMID 42390481
Unclassified: not yet indexed with MeSH (4)
  1. Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma. Cell cycle (Georgetown, Tex.) · 15 Jul 2026 PMID 42454783
  2. Integration of bulk RNA-seq and scRNA-seq reveals cell subsets and gene signatures associated with Glaesserella parasuis infection. BMC genomics · 7 Jul 2026 PMID 42410501
  3. Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration. Journal of hepatology · 1 Jul 2026 PMID 42385858
  4. Multi-omics analysis identifies GINS1 as a prognostic biomarker in lung adenocarcinoma, linked to macrophage polarization and tumor cell survival. Discover oncology · 15 Jun 2026 PMID 42295485